Treatment of Diabetic Foot Ulcer Using Matriderm In Comparison with a Skin Graft

 

 Permissions and Reprints

Background For patients with neuropathy, vasculopathy, and impairment of wound healing, treatment of a diabetic foot ulcer poses many challenges. A large number of dermal analogues have been invented in an effort to overcome these challenges. Matriderm, a dermal analogue, is made from bovine collagen and elastin. This study was conducted in order to evaluate the effectiveness of Matriderm for treatment of diabetic foot ulcers, in comparison with skin grafting.

Methods Sixty patients with diabetic foot ulcer were included in this prospective study. The average age of the patients, who had type II diabetes mellitus, was 58 years old. The patients were allocated to an experimental or control group with their consents. The patients were selected with their consent for inclusion in an experimental group and a control group. Patients in the experimental group received a Matriderm appliance and a split-thickness skin graft, while those in the control group received only a split-thickness skin graft.

Results A shorter hospitalization period (7.52 weeks) was observed in the experimental group than in the control group (9.22 weeks), and a shorter period of time (8.61 weeks) was required for complete healing, compared with the control group (12.94 weeks), with statistical significance (P<0.05). A higher elasticity ratio of the affected side to the non-affected side was observed in the experimental group, compared with the control group (P<0.01).

Conclusions Matriderm enables effective healing and improves elasticity in treatment of patients with diabetic foot ulcer.

This article was presented at the 70th Congress of the Korean Society of Plastic and Reconstructive Surgeons on November 9-11, 2012 in Seoul, Korea.

Publication History

Received: 19 March 2013

Accepted: 20 June 2013

Article published online:
01 May 2022

© 2013. The Korean Society of Plastic and Reconstructive Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonCommercial License, permitting unrestricted noncommercial use, distribution, and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes. (https://creativecommons.org/licenses/by-nc/4.0/)

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

• References

• 1 Chung CH, Kim DJ, Kim J. et al. Current status of diabetic foot in Korean patients using national health insurance database. J Korean Diabetes Assoc 2006; 30: 372-376
  CrossrefGoogle Scholar
• 2 Greenhalgh DG. Wound healing and diabetes mellitus. Clin Plast Surg 2003; 30: 37-45
  CrossrefPubMedGoogle Scholar
• 3 Kim SH, Kim JW, Kim JB. et al. Multifactorial factors of diabetic foot on diabetes mellitus comparative clinical study. J Korean Soc Plast Reconstr Surg 2002; 29: 83-90
  Google Scholar
• 4 Hanft JR, Surprenant MS. Healing of chronic foot ulcers in diabetic patients treated with a human fibroblast-derived dermis. J Foot Ankle Surg 2002; 41: 291-299
  CrossrefPubMedGoogle Scholar
• 5 Wetzig T, Gebhardt C, Simon JC. New indications for artificial collagen-elastin matrices? Covering exposed tendons. Dermatology 2009; 219: 272-273
  CrossrefPubMedGoogle Scholar
• 6 Wagner Jr FW. The diabetic foot. Orthopedics 1987; 10: 163-172
  CrossrefPubMedGoogle Scholar
• 7 Lavery LA, Armstrong DG, Murdoch DP. et al. Validation of the Infectious Diseases Society of America's diabetic foot infection classification system. Clin Infect Dis 2007; 44: 562-565
  CrossrefPubMedGoogle Scholar
• 8 Hashmi F, Malone-Lee J. Measurement of skin elasticity on the foot. Skin Res Technol 2007; 13: 252-258
  CrossrefPubMedGoogle Scholar
• 9 Eum SJ, Han SK, Gu JH. et al. Treatment of diabetic ulcer using autologous fibroblast-hyaluronic acid complex. J Korean Soc Plast Reconstr Surg 2009; 36: 548-554
  Google Scholar
• 10 Cuono C, Langdon R, McGuire J. Use of cultured epidermal autografts and dermal allografts as skin replacement after burn injury. Lancet 1986; 1: 1123-1124
  PubMedGoogle Scholar
• 11 Hamuy R, Kinoshita N, Yoshimoto H. et al. One-stage, simultaneous skin grafting with artificial dermis and basic fibroblast growth factor successfully improves elasticity with maturation of scar formation. Wound Repair Regen 2013; 21: 141-154
  CrossrefPubMedGoogle Scholar
• 12 Han SK, You HJ. Wound coverage using advanced technology in Korea. J Korean Med Assoc 2011; 54: 594-603
  CrossrefGoogle Scholar
• 13 Young MJ, Adams JE, Anderson GF. et al. Medial arterial calcification in the feet of diabetic patients and matched non-diabetic control subjects. Diabetologia 1993; 36: 615-621
  CrossrefPubMedGoogle Scholar
• 14 Weiner RD, Hlad LM, McKenna DR. Recurrence of diabetic pedal ulcerations following tendo-achilles lengthening. Diabet Foot Ankle 2011; 2: 6417
  Google Scholar
• 15 Reddy GK. Cross-linking in collagen by nonenzymatic glycation increases the matrix stiffness in rabbit achilles tendon. Exp Diabesity Res 2004; 5: 143-153
  CrossrefPubMedGoogle Scholar